IMPRIMIS PHARMACEUTICALS INC's ticker is IMMY and the CUSIP is 45323A201. A total of 26 filers reported holding IMPRIMIS PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $14,000 | +100.0% | 2,400 | -9.2% | 0.00% | – |
| Q3 2018 | $7,000 | -30.0% | 2,642 | -41.3% | 0.00% | – |
| Q2 2018 | $10,000 | +42.9% | 4,500 | +15.4% | 0.00% | – |
| Q1 2018 | $7,000 | +133.3% | 3,900 | +160.0% | 0.00% | – |
| Q4 2017 | $3,000 | +50.0% | 1,500 | 0.0% | 0.00% | – |
| Q3 2017 | $2,000 | -60.0% | 1,500 | 0.0% | 0.00% | – |
| Q2 2017 | $5,000 | -93.8% | 1,500 | -92.2% | 0.00% | – |
| Q1 2017 | $80,000 | +81.8% | 19,221 | +8.5% | 0.00% | – |
| Q4 2016 | $44,000 | -35.3% | 17,721 | 0.0% | 0.00% | – |
| Q3 2016 | $68,000 | +1.5% | 17,721 | -0.4% | 0.00% | – |
| Q2 2016 | $67,000 | -4.3% | 17,797 | +0.4% | 0.00% | – |
| Q1 2016 | $70,000 | -83.1% | 17,721 | -72.6% | 0.00% | – |
| Q3 2015 | $415,000 | -21.1% | 64,699 | 0.0% | 0.00% | – |
| Q2 2015 | $526,000 | -13.3% | 64,699 | -14.8% | 0.00% | – |
| Q1 2015 | $607,000 | +6.5% | 75,949 | 0.0% | 0.00% | – |
| Q4 2014 | $570,000 | +1.1% | 75,949 | 0.0% | 0.00% | – |
| Q3 2014 | $564,000 | +6.0% | 75,949 | -1.0% | 0.00% | – |
| Q2 2014 | $532,000 | +4.3% | 76,698 | +1.0% | 0.00% | – |
| Q1 2014 | $510,000 | – | 75,949 | +1265716.7% | 0.00% | – |
| Q4 2013 | $0 | – | 6 | -33.3% | 0.00% | – |
| Q2 2013 | $0 | – | 9 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|